04777nam 2200649Ia 450 991077867910332120230213211000.01-280-24677-497866102467790-309-58152-40-585-14491-5(CKB)110986584750692(EBL)3376089(SSID)ssj0000266426(PQKBManifestationID)11206711(PQKBTitleCode)TC0000266426(PQKBWorkID)10301177(PQKB)11591059(MiAaPQ)EBC3376089(Au-PeEL)EBL3376089(CaPaEBR)ebr10055083(CaONFJC)MIL24677(OCoLC)923261025(EXLCZ)9911098658475069219851205d1985 uy 0engur|n|---|||||txtccrVaccine supply and innovation[electronic resource] /Division of Health Promotion and Disease Prevention, Institute of MedicineWashington, D.C. National Academy Press19851 online resource (210 p.)Publication IOM ;no. 85-02Description based upon print version of record.0-309-03544-9 Includes bibliographical references.""Vaccine Supply and Innovation""; ""Copyright""; ""Preface""; ""Contents""; ""Vaccine Supply and Innovation""; ""1 Summary""; ""OVERVIEW""; ""VACCINE AVAILABILITY: MAJOR BARRIERS AND IMPEDIMENTS""; ""Impediments to Vaccine Innovation""; ""ECONOMIC CHARACTERISTICS OF THE VACCINE INDUSTRY""; ""VACCINE INJURY""; ""THE LEGAL SITUATION AND ITS CONSEQUENCES""; ""CONSEQUENCES OF THE STATE OF VACCINE INJURY LIABILITY LAW FOR VACCINE PRODUCTION AND INNOVATION""; ""A NATIONAL VACCINE COMMISSION""; ""COMPENSATION AND LIABILITY FOR VACCINE-RELATED INJURY""; ""2 Vaccines: Past, Present, and Future""""TYPES OF IMMUNIZATION""""HISTORY OF IMMUNIZATION""; ""THE PRESENT""; ""Development of Vaccines and Recommendations for Vaccine Use""; ""THE FUTURE""; ""REFERENCES AND NOTES""; ""3 Vaccine Availability: Concerns, Barriers, and Impediments""; ""CONCERNS ABOUT THE CURRENT SITUATION""; ""Supply""; ""Stockpiling of Vaccines""; ""Problems with Sole Reliance on Foreign Manufacturers""; ""Federal Action to Ensure Vaccine Supply""; ""BARRIERS AND IMPEDIMENTS TO VACCINE INNOVATION""; ""Identification of Need and Establishing Priorities""""Establishing the Technical Feasibility of Vaccine Development""""Economic Disincentives to Innovation and Production""; ""Factors Influencing the Market for Vaccines""; ""VACCINE UTILIZATION""; ""System Factors""; ""Client Factors""; ""Provider Factors""; ""CONCLUSIONS""; ""Barriers and Impediments to Vaccine Innovation""; ""REFERENCES AND NOTES""; ""4 Economic Aspects of Vaccine Innovation and Manufacturing""; ""POTENTIAL CAUSES OF INDUSTRY DECLINE""; ""Property Rights and Innovation""; ""Regulation""; ""Market Size""; ""Liability and Risk""; ""DESCRIPTIVE STATISTICS""""The Market and Participants""""Pricing""; ""Research and Development""; ""CONCLUSIONS""; ""REFERENCES AND NOTES""; ""5 Vaccine Injury""; ""The Pertussis Controversy""; ""Identifying Individuals at High Risk of Adverse Effects""; ""VACCINES USED IN CHILDHOOD""; ""Pertussis Vaccine""; ""Diphtheria Toxoid""; ""Tetanus Toxoid""; ""Poliomyelitis Vaccines""; ""Measles Vaccine""; ""Rubella Vaccine""; ""Mumps Vaccine""; ""VACCINES FOR ADULTS""; ""Influenza Vaccines""; ""Pneumococcal Vaccines""; ""Meningococcal Vaccines""; ""Rabies Vaccine""; ""Hepatitis B Vaccine""; ""SUMMARY""""REFERENCES AND NOTES""""6 Liability for the Production and Sale of Vaccines ""; ""STATE OF THE LAW""; ""Experience From the Swine Flu Vaccination Program""; ""Recent Trends""; ""The Issue of Punitive Damages""; ""Summary of the Legal Situation""; ""CONSEQUENCES OF THE STATE OF VACCINE INJURY LIABILITY LAW FOR VACCINE PRODUCTION AND INNOVATION""; ""REFERENCES AND NOTES""; ""7 An Approach to the Problems of Communication, Coordination, and Collaboration in Vaccine Policy""; ""HISTORICAL BACKGROUND""; ""THE EXISTING STRUCTURE""; ""Federal Agency Interactions""""Public-Private Sector Interactions""IOM publication ;85-02.VaccinesResearchImmunizationVaccinesResearch.Immunization.338.47615372Institute of Medicine (U.S.).Division of Health Promotion and Disease Prevention.MiAaPQMiAaPQMiAaPQBOOK9910778679103321Vaccine supply and innovation3791535UNINA